Lucid Diagnostics
LUCD
23 hedge funds and large institutions have $3.52M invested in Lucid Diagnostics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 11 closing their positions.
0.5% less ownership
Funds ownership: 6.48% → 5.97% (-0.5%)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
26% less funds holding
Funds holding: 31 → 23 (-8)
36% less capital invested
Capital invested by funds: $5.52M → $3.52M (-$1.99M)
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$80.4K |
| 2 |
Jane Street
New York
|
+$38.8K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$18.1K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$172K |
| 2 |
Morgan Stanley
New York
|
-$97.3K |
| 3 |
LM
Luminus Management
Houston,
Texas
|
-$67.5K |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$56.1K |
| 5 |
E
Ergoteles
New York
|
-$50K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCWM
26
Total Clarity Wealth Management
St. Charles,
Illinois
| – | -$1K | -500 | Closed |
|
27
Osaic Holdings
Scottsdale,
Arizona
| – | -$572 | -230 | -42% |
|
28
Wells Fargo
San Francisco,
California
| – | +$50 | +20 | +56% |
|
LUCD Hedge Fund Activity: Q3 2022 in Review
23 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q3 2022, worth a combined $3.52M — down 36% from $5.52M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of LUCD and 3 opened new positions — a net loss of 8 holders — while 8 trimmed existing stakes and 6 added.
The largest buyer was Vanguard Group, adding an estimated $80.4K. The largest seller was Cantor Fitzgerald, cutting an estimated $172K.
- 23 institutional investors held Lucid Diagnostics (LUCD) as of Q3 2022, down from 31 in Q2 2022.
- Funds reported $3.52M of Lucid Diagnostics stock for Q3 2022, down 36% quarter-over-quarter.
- 3 funds opened new Lucid Diagnostics positions in Q3 2022 and 11 closed out, a net change of -8 holders.
- The largest Lucid Diagnostics buyer in Q3 2022 was Vanguard Group, an estimated $80.4K added.
- The largest Lucid Diagnostics seller in Q3 2022 was Cantor Fitzgerald, an estimated $172K sold.
Based on aggregated 13F filings for Q3 2022.